Home
>
National Drug Code (NDC)
>
CeraVe
CeraVe - 0187-1366-03 - (Homosalate, Octinoxate, Zinc Oxide, and Octocrylene)
Drug Information of CeraVe
| Product NDC: | 0187-1366 |
| Proprietary Name: | CeraVe |
| Non Proprietary Name: | Homosalate, Octinoxate, Zinc Oxide, and Octocrylene |
| Active Ingredient(s): | 124; 77; 21; 36 mg/mL; mg/mL; mg/mL; mg/mL & nbsp; Homosalate, Octinoxate, Zinc Oxide, and Octocrylene |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CeraVe
| Product NDC: | 0187-1366 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20121002 |
Package Information of CeraVe
| Package NDC: | 0187-1366-03 |
| Package Description: | 89 mL in 1 BOTTLE, PLASTIC (0187-1366-03) |
NDC Information of CeraVe
| NDC Code | 0187-1366-03 |
| Proprietary Name | CeraVe |
| Package Description | 89 mL in 1 BOTTLE, PLASTIC (0187-1366-03) |
| Product NDC | 0187-1366 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Homosalate, Octinoxate, Zinc Oxide, and Octocrylene |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20121002 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | HOMOSALATE; OCTINOXATE; OCTOCRYLENE; ZINC OXIDE |
| Strength Number | 124; 77; 21; 36 |
| Strength Unit | mg/mL; mg/mL; mg/mL; mg/mL |
| Pharmaceutical Classes |
